YaFarm Technologies Announces ISCI Release of Patient Publications
04 Marzo 2013 - 1:30PM
Marketwired
YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the
Company) is pleased to announce the Integrative Stem Cell Institute
(ISCI) has released three proprietary documents for patients
seeking stem cell based therapies. These documents concerning stem
cell procedures will be available to both new and existing
patients.
The three articles that the ISCI has published are:
The ISCI Vetting Stem Cell Clinics provides a clear and concise
overview of areas patients need to investigate prior to seeking
stem cell therapy. The article provides information on how to
evaluate claims made by the clinic, the importance of independent
review of the treatments, as well as an explanation about the
importance of long-term follow up.
http://iscelli.com/vettingstemcellclinics.php
20 Questions to Ask a Physician provides critical questions
patients should ask before seeking treatment. Patients are urged to
read the article, which discusses how cells are removed and
injected into the patients, as well as how to determine the
qualification of the physicians.
http://iscelli.com/questionstoask.php
Patient Rights details patient rights and includes a thorough
discussion on how patients should be treated by clinics and
physicians. It also sets expectations of treatment while defining
the level of care and service to be afforded to all patients. The
ISCI believes patients should understand their role in a clinical
study and understand there can be no guarantees.
http://iscelli.com/patientsrights.php
"The ISCI has set the bar extremely high," said David Audley,
CEO of the ISCI. "No other clinic has taken such a bold, public
stance on patient care and safety. These documents are a powerful
collection of questions and observations that range from collection
and processing of cells, to outcome tracking and access to access
to medical records. These are the most complete and comprehensive
set of views to protect and educate patients. We believe we have
set the standard for every clinic, while enshrining transparency
and protecting patient safety."
About Integrative Stem Cell Institute
(ISCI) The Integrative Stem Cell Institute (ISCI) is a premier
provider of point-of-care, stem cell-based therapies for patients
from around the world. With a state of the art laboratory housed
within the Hospital Galenia in Cancun, Mexico, the ISCI combines
the most advanced scientific application of stem cells with second
to none medical care within the structure of adaptive clinical
trials to effectively track long term outcomes and assure patient
safety. More information on the Integrative Stem Cell Institute is
available at www.iscelli.com
SAFE HARBOR STATEMENT
This press release may contain certain forward-looking
statements and information, as defined within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor
created by those sections. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted or quantified. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, adequate financing, and
other material risks. Such forward-looking statements by definition
involve risks, uncertainties and other factors, which may cause the
actual results, performance, or achievements to be materially
different from the statements made herein.
Contact: The Integrative Stem Cell Institute Contact: Miranda
Abrahams Miranda@iscelli.com Investor Contact Atlanta Capital
Partners, LLC David Kugelman (866) 692-6847 info@atlcp.com
Grafico Azioni Profile Solutions (CE) (USOTC:PSIQ)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Profile Solutions (CE) (USOTC:PSIQ)
Storico
Da Set 2023 a Set 2024